XML 35 R20.htm IDEA: XBRL DOCUMENT v3.6.0.2
CAPITAL STOCK
12 Months Ended
Dec. 31, 2016
CAPITAL STOCK  
CAPITAL STOCK

13. CAPITAL STOCK

Our authorized capital stock consists of 2,000,000 preferred shares, none of which were issued or outstanding at December 31, 2016, 2015 and 2014, and 120,000,000 common shares, no par value per share, of which the following shares were outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

    

2016

    

2015

    

2014

 

Shares outstanding as of December 31, 

 

 

51,527,711

 

 

51,501,877

 

 

50,284,007

 

Summary of Share Issuances:

 

 

 

 

 

 

 

 

 

 

Share Issuances related to Equity Compensation:

 

 

 

 

 

 

 

 

 

 

Shares issued upon exercise of stock options by employees

 

 

25,834

 

 

657,998

 

 

711,516

 

Proceeds realized from stock option exercises

 

$

80,161

 

$

2,780,188

 

$

2,964,445

 

Average exercise price of options exercised

 

$

3.10

 

$

4.23

 

$

4.17

 

Restricted Stock Grants

 

 

 —

 

 

850,000

 

 

740,000

 

Share issuances related to Warrant Exercises

 

 

 

 

 

 

 

 

 

 

Shares issued upon the exercise of warrants

 

 

 —

 

 

 

 

 

904,886

 

Proceeds realized from warrant exercises

 

 

 —

 

 

 

 

$

8,433,045

 

Share issuances related to Equity Offerings

 

 

 

 

 

 

 

 

 

 

Shares issued pursuant to equity offerings

 

 

 —

 

 

 

 

 

7,816,944

 

Proceeds realized from equity offerings

 

 

 —

 

 

 

 

$

69,780,967

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Shares

Holders of the common shares are entitled to one vote per share on all matters submitted to a vote of our shareholders and are entitled to receive dividends when and if declared by the Board of Directors. The Board is authorized to issue additional common shares within the limits of the Company’s Articles of Incorporation without further shareholder action, subject to applicable stock exchange rules.

Warrants

As of December 31, 2016 and 2015, we had no outstanding warrants.  During 2014, we realized $8,433,045 in net proceeds from the exercise of 904,886 warrants at an average exercise price of $9.32.